Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate

Genesis (United States)

Volumn 45, Issue 1, 2007, Pages 11-16

  Kiermayer, Claudia ^a   Conrad, Marcus ^a   Schneider, Manuela ^a   Schmidt, Jörg ^a   Brielmeier, Markus ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Cre recombinase; Inducible gene expression; MerCreMer; Mitochondrial thioredoxin reductase; Oral administration; Tamoxifen citrate salt

Indexed keywords

ALCOHOL; CRE RECOMBINASE; ESTROGEN RECEPTOR; OIL; TAMOXIFEN CITRATE; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE INACTIVATION; GENE INDUCTION; GENE MUTATION; HEART DEVELOPMENT; KNOCKOUT MOUSE; LETHALITY; LIGAND BINDING; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; STRESS; TISSUE SPECIFICITY;

MUS;

EID: 33846828631     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20244     Document Type: Article

References (25)

1. Agger K, Santoni-Rugiu E, Holmberg C, Karlstrom O, Helin K. 2005. Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS. Oncogene 24:780-789.
2. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, Chambon P, Metzger D. 1997. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci USA 94:14559-14563.
3. Casanova E, Fehsenfeld S, Lemberger T, Shimshek DR, Sprengel R, Mantamadiotis T. 2002. ER-based double iCre fusion protein allows partial recombination in forebrain. Genesis 34:208-214.
4. Conrad M, Jakupoglu C, Moreno SG, Lippl S, Banjac A, Schneider M, Beck H, Hatzopoulos AK, Just U, Sinowatz F, Schmahl W, Chien KR, Wurst W, Bornkamm GW, Brielmeier M. 2004. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24:9414-9423.
5. Forde A, Constien R, Grone HJ, Hammerling G, Arnold B. 2002. Temporal Cre-mediated recombination exclusively in endothelial cells using Tie2 regulatory elements. Genesis 33:191-197.
6. Holmgren A, Bjornstedt M. 1995. Thioredoxin and thioredoxin reductase. Methods Enzymol 252:199-208.
7. Indra AK, Dupe V, Bornert JM, Messaddeq N, Yaniv M, Mark M, Chambon P, Metzger D. 2005. Temporally controlled targeted somatic mutagenesis in embryonic surface ectoderm and fetal epidermal keratinocytes unveils two distinct developmental functions of BRG1 in limb morphogenesis and skin barrier formation. Development 132:4533-4544.
8. Kostetskii I, Li J, Xiong Y, Zhou R, Ferrari VA, Patel W, Molkentin JD, Radice GL. 2005. Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res 96:346-354.
9. Leone DP, Genoud S, Atanasoski S, Grausenburger R, Berger P, Metzger D, Macklin WB, Chambon P, Suter U. 2003. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol Cell Neurosci 22:430-440.
10. Li M, Indra AK, Warot X, Brocard J, Messaddeq N, Kato S, Metzger D, Chambon P. 2000. Skin abnormalities generated by temporally controlled RXRα mutations in mouse epidermis. Nature 407:633-636.
11. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 23:1686-1690.
12. Metzger D, Chambon P. 2001. Site- and time-specific gene targeting in the mouse. Methods 24:71-80.
13. Mijimolle N, Velasco J, Dubus P, Guerra C, Weinbaum CA, Casey PJ, Campuzano V, Barbacid M. 2005. Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development. Cancer Cell 7:313-324.
14. Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, Hofmann F, Klugbauer N. 2003. Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J 22:6027-6034.
15. Nordenskjold B, Rosell J, Rutqvist LE, Malmstrom PO, Bergh J, Bengtsson NO, Hatschek T, Wallgren A, Carstensen J. 2005. Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: Results from a randomized trial. J Natl Cancer Inst 97:1609, 1610.
16. Petrich BG, Molkentin JD, Wang Y. 2003. Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination. FASEB J 17:749-751.
17. Poon GK, Walter B, Lonning PE, Horton MN, McCague R. 1995. Identification of tamoxifen metabolites in human Hep G2 cell line, human liver homogenate, and patients on long-term therapy for breast cancer. Drug Metab Dispos 23:377-382.
18. Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC. 1991. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos 19:36-43.
19. Rundlof AK, Janard M, Miranda-Vizuete A, Arner ES. 2004. Evidence for intriguingly complex transcription of human thioredoxin reductase 1. Free Radic Biol Med 36:641-656.
20. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD. 2001. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 89:20-25.
21. Sun QA, Zappacosta F, Factor VM, Wirth PJ, Hatfield DL, Gladyshev VN. 2001. Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. J Biol Chem 276:3106-3114.
22. Trump DL, Smith DC, Ellis PG, Rogers MP, Schold SC, Winer EP, Panella TJ, Jordan VC, Fine RL. 1992. High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: Phase I trial in combination with vinblastine. J Natl Cancer Inst 84:1811-1816.
23. Xiao G, Mao S, Baumgarten G, Serrano J, Jordan MC, Roos KP, Fishbein MC, MacLellan WR. 2001. Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res 89:1122-1129.
24. Yu D, Dews M, Park A, Tobias JW, Thomas-Tikhonenko A. 2005. Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: Implications for adjuvant therapies. Cancer Res 65:5454-5461.
25. Zhang Y, Riesterer C, Ayrall AM, Sablitzky F, Littlewood TD, Reth M. 1996. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res 24:543-548.